APOA1 and Alzheimer disease: Consistent with the reduced peripheral APOA-I levels, CSF APOA-I concentrations are also significantly decreased in AD patients [27,70,71], indicating that the downregulation of APOA-I is closely associated with the onset and progression of AD.